Targovax – Therapeutic cancer vaccines

Targovax is an innovation driven specialist in immuno-oncology.

People with identical cancer diagnoses do not have identical diseases. Their cells vary in the way they look, function and are seen by the immune system – the body’s own defence against cancer. At Targovax, we are developing cancer specific therapies that activate each patient’s own immune system to fight against their disease.

Read more

"Even in late stage cancer patients with low immunogenic tumor types, our virus-based immunotherapy can reinstate the immune system’s ability to recognise and attack cancer cells. In addition, studies with our peptide-based Immunotherapy have shown immune responses in difficult to treat RAS cancer patients."

Sari Pesonen & Tone Otterhaug, Clinical Research, Targovax

Read more

Hear from Magnus Jäderberg, CMO of Targovax on PharmaTV why its immuno-oncology pipeline offers something both different and complementary to the most exciting recent advances in this field.

Read more

Current Opportunities

Targovax is actively recruiting for specific positions. Please see:

View all positions